The Effect of Levosimendan in Rat Mesenteric Ischemia/Reperfusion Injury

REFERENCES

• Cerqueira NF, Hussni CA, Yoshida WB. Pathophysiology of mesenteric ischemia/reperfusion: a review. Acta Cir Bras. 2005;20:336–343.
   PubMedGoogle Scholar
• Vinardi S, Pierro A, Parkinson EJ, Hypothermia throughout intestinal ischaemia-reperfusion injury attenuates lung neutrophil infiltration. J Pediatr Surg. 2003;38:88–91; discussion 88–91.
   PubMed Web of Science ®Google Scholar
• Parks DA, Granger DN. Contributions of ischemia and reperfusion to mucosal lesion formation. Am J Physiol. 1986;250:G749–G753.
   PubMed Web of Science ®Google Scholar
• Rudiger HA, Clavien PA. Tumor necrosis factor alpha, but not Fas, mediates hepatocellular apoptosis in the murine ischemic liver. Gastroenterology. 2002;122:202–210.
   PubMed Web of Science ®Google Scholar
• Abraham E. Neutrophils and acute lung injury. Crit Care Med. 2003;31:S195–S199.
   PubMed Web of Science ®Google Scholar
• Koksoy C, Kuzu MA, Ergun H, Intestinal ischemia and reperfusion impairs vasomotor functions of pulmonary vascular bed. Ann Surg. 2000;231:105–111.
   PubMed Web of Science ®Google Scholar
• Innes CA, Wagstaff AJ. Levosimendan: a review of its use in the management of acute decompensated heart failure. Drugs. 2003;63:2651–2671.
   PubMed Web of Science ®Google Scholar
• Kersten JR, Montgomery MW, Pagel PS, Levosimendan, a new positive inotropic drug, decreases myocardial infarct size via activation of K(ATP) channels. Anesth Analg. 2000;90:5–11.
   PubMed Web of Science ®Google Scholar
• Revermann M, Schloss M, Mieth A, Levosimendan attenuates pulmonary vascular remodeling. Intensive Care Med. 2011;37:1368–1377.
   PubMed Web of Science ®Google Scholar
• Hasslacher J, Bijuklic K, Bertocchi C, Levosimendan inhibits release of reactive oxygen species in polymorphonuclear leukocytes in vitro and in patients with acute heart failure and septic shock: a prospective observational study. Crit Care. 2011;15:R166.
   PubMed Web of Science ®Google Scholar
• Parissis JT, Andreadou I, Markantonis SL, Effects of Levosimendan on circulating markers of oxidative and nitrosative stress in patients with advanced heart failure. Atherosclerosis. 2007;195:e210–e215.
   PubMed Web of Science ®Google Scholar
• Megison SM, Horton JW, Chao H, A new model for intestinal ischemia in the rat. J Surg Res. 1990;49:168–173.
   PubMed Web of Science ®Google Scholar
• Livak KJ, Schmittgen TD. Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. Methods. 2001;25:402–408.
   PubMed Web of Science ®Google Scholar
• Park PO, Haglund U, Bulkley GB, The sequence of development of intestinal tissue injury after strangulation ischemia and reperfusion. Surgery. 1990;107:574–580.
   PubMed Web of Science ®Google Scholar
• Carden DL, Granger DN. Pathophysiology of ischaemia-reperfusion injury. J Pathol. 2000;190:255–266.
   PubMed Web of Science ®Google Scholar
• Yao YM, Sheng ZY, Yu Y, The potential etiologic role of tumor necrosis factor in mediating multiple organ dysfunction in rats following intestinal ischemia-reperfusion injury. Resuscitation. 1995;29:157–168.
   PubMed Web of Science ®Google Scholar
• Yamada T, Murase N, Maeda T, Protective effect of TNF-alpha and IL-1 beta inhibitor FR167653 on ischemia-reperfusion injury in rat small intestinal transplantation. Transplant Proc. 1998;30:2638.
   PubMed Web of Science ®Google Scholar
• Sun Z, Wang X, Lasson A, Roles of platelet-activating factor, interleukin-1beta and interleukin-6 in intestinal barrier dysfunction induced by mesenteric arterial ischemia and reperfusion. J Surg Res. 1999;87:90–100.
   PubMed Web of Science ®Google Scholar
• Nezu Y, Shigihara K, Harada Y, Effects of small intestinal ischemia and reperfusion on expression of tumor necrosis factor-alpha and interleukin-6 messenger RNAs in the jejunum, liver, and lungs of dogs. Am J Vet Res. 2008;69:512–518.
   PubMed Web of Science ®Google Scholar
• Brandt LJ, Boley SJ. Sleinsenger and Fordtran's gastrointestinal and liver disease. Intestinal ischemia. Philadelphia, IL: Feldman M, Friedman IS, Sleisenger MH. Saunders. 2002:2321–2340.
   Google Scholar
• Collard CD, Gelman S. Pathophysiology, clinical manifestations, and prevention of ischemia-reperfusion injury. Anesthesiology. 2001;94:1133–1138.
   PubMed Web of Science ®Google Scholar
• Saugstad OD. Hypoxanthine as an indicator of hypoxia: its role in health and disease through free radical production. Pediatr Res. 1988;23:143–150.
   PubMed Web of Science ®Google Scholar
• Tsuruma T, Yagihashi A, Matsuno T, The heat-shock protein 70 family reduces ischemia/reperfusion injury in small intestine. Transplant Proc. 1996;28:2629–2630.
   PubMed Web of Science ®Google Scholar
• Nezu Y, Tagawa M, Sakaue Y, Kinetics of endotoxin concentration and tumor necrosis factor-alpha, interleukin-1beta, and interleukin-6 activities in the systemic and portal circulation during small intestinal ischemia and reperfusion in dogs. Am J Vet Res. 2002;63:1680–1686.
   PubMed Web of Science ®Google Scholar
• Follath F, Cleland JG, Just H, Efficacy and safety of intravenous levosimendan compared with dobutamine in severe low-output heart failure (the LIDO study): a randomised double-blind trial. Lancet. 2002;360:196–202.
   PubMed Web of Science ®Google Scholar
• Sorsa T, Pollesello P, Permi P, Interaction of levosimendan with cardiac troponin C in the presence of cardiac troponin I peptides. J Mol Cell Cardiol. 2003;35:1055– 1061.
   PubMed Web of Science ®Google Scholar
• Boknik P, Neumann J, Kaspareit G, Mechanisms of the contractile effects of levosimendan in the mammalian heart. J Pharmacol Exp Ther. 1997;280:277–283.
   PubMed Web of Science ®Google Scholar
• Hasenfuss G, Pieske B, Castell M, Influence of the novel inotropic agent levosimendan on isometric tension and calcium cycling in failing human myocardium. Circulation. 1998;98:2141–2147.
   PubMed Web of Science ®Google Scholar
• Brixius K, Reicke S, Schwinger RH. Beneficial effects of the Ca(2+) sensitizer levosimendan in human myocardium. Am J Physiol Heart Circ Physiol. 2002;282:H131–H137.
   Web of Science ®Google Scholar
• Malmberg M, Vahasilta T, Saraste A, Intracoronary levosimendan during ischemia prevents myocardial apoptosis. Front Physiol. 2012;3:17.
   PubMed Web of Science ®Google Scholar
• Yasa H, Yakut N, Emrecan B, Protective effects of levosimendan and iloprost on lung injury induced by limb ischemia-reperfusion: a rabbit model. J Surg Res. 2008;147:138–142.
   PubMed Web of Science ®Google Scholar
• Katircioglu SF, Seren M, Parlar AI, Levosimendan effect on spinal cord ischemia-reperfusion injury following aortic clamping. J Card Surg. 2008;23:44–48.
   PubMed Web of Science ®Google Scholar
• Takizawa Y, Kishimoto H, Kitazato T, Changes in the localization of ileal P-glycoprotein induced by intestinal ischemia/reperfusion. Biol Pharm Bull. 2011;34:408–414.
   PubMed Web of Science ®Google Scholar
• Valen G, Yan ZQ, Hansson GK. Nuclear factor kappa-B and the heart. J Am Coll Cardiol. 2001;38:307–314.
   PubMed Web of Science ®Google Scholar
• Cleveland JL, Ihle JN. Contenders in FasL/TNF death signaling. Cell. 1995;81:479–482.
   PubMed Web of Science ®Google Scholar
• Lee JI, Burckart GJ. Nuclear factor kappa B: important transcription factor and therapeutic target. J Clin Pharmacol. 1998;38:981–993.
   PubMed Web of Science ®Google Scholar
• Karin M. The beginning of the end: IkappaB kinase (IKK) and NF-kappaB activation. J Biol Chem. 1999;274:27339–27342.
   PubMed Web of Science ®Google Scholar
• Albayrak Y, Halici Z, Odabasoglu F, The effects of testosterone on intestinal ischemia/reperfusion in rats. J Invest Surg 2011; 24:283–291.
   PubMed Web of Science ®Google Scholar
• Oral A, Odabasoglu F, Halici Z, Protective effects of montelukast on ischemia-reperfusion injury in rat ovaries subjected to torsion and detorsion: biochemical and histopathologic evaluation. Fertil Steril. 2011;95:1360–1366.
   PubMed Web of Science ®Google Scholar
• Cadirci E, Oral A, Odabasoglu F, Atorvastatin reduces tissue damage in rat ovaries subjected to torsion and detorsion: biochemical and histopathologic evaluation. Naunyn Schmiedebergs Arch Pharmacol. 2010;381:455–466.
   PubMed Web of Science ®Google Scholar
• Halici Z, Karaca M, Keles ON, Protective effects of amlodipine on ischemia-reperfusion injury of rat ovary: biochemical and histopathologic evaluation. Fertil Steril. 2008;90:2408–2415.
   PubMed Web of Science ®Google Scholar
• Kruidenier L, van Meeteren ME, Kuiper I, Attenuated mild colonic inflammation and improved survival from severe DSS-colitis of transgenic Cu/Zn-SOD mice. Free Radic Biol Med. 2003;34:753–765.
   Google Scholar
• Oktar BK, Gulpinar MA, Bozkurt A, Endothelin receptor blockers reduce I/R-induced intestinal mucosal injury: role of blood flow. Am J Physiol Gastrointest Liver Physiol. 2002;282:G647–G655.
   Web of Science ®Google Scholar
• Seyhan N, Canseven AG. In vivo effects of ELF MFs on collagen synthesis, free radical processes, natural antioxidant system, respiratory burst system, immune system activities, and electrolytes in the skin, plasma, spleen, lung, kidney, and brain tissues. Electromagn Biol Med. 2006;25:291–305.
   PubMed Web of Science ®Google Scholar
• Suzer T, Coskun E, Demir S, Lipid peroxidation and glutathione levels after cortical injection of ferric chloride in rats: effect of trimetazidine and deferoxamine. Res Exp Med (Berl). 2000;199:223–229.
   PubMedGoogle Scholar
• Paller MS, Patten M. Protective effects of glutathione, glycine, or alanine in an in vitro model of renal anoxia. J Am Soc Nephrol. 1992;2:1338–1344.
   PubMed Web of Science ®Google Scholar
• Reiter RJ, Tan DX, Sainz RM, Melatonin: reducing the toxicity and increasing the efficacy of drugs. J Pharm Pharmacol. 2002;54:1299–1321.
   PubMed Web of Science ®Google Scholar
• Yigiter M, Halici Z, Odabasoglu F, Growth hormone reduces tissue damage in rat ovaries subjected to torsion and detorsion: biochemical and histopathologic evaluation. Eur J Obstet Gynecol Reprod Biol. 2011;157:94–100.
   PubMed Web of Science ®Google Scholar
• Sakamoto M, Takaki E, Yamashita K, Nonenzymatic derived lipid peroxide, 8-iso-PGF2 alpha, participates in the pathogenesis of delayed cerebral vasospasm in a canine SAH model. Neurol Res. 2002;24:301–306.
   PubMed Web of Science ®Google Scholar
• Basu S, Hellberg A, Ulus AT, Biomarkers of free radical injury during spinal cord ischemia. FEBS Lett. 2001;508:36–38.
   PubMed Web of Science ®Google Scholar